Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Two River is a venture capital organization founded to build life science companies by partnering with scientific founders and experienced management teams. Established in New York, the firm focuses on leveraging its capital to invest in companies with strong intellectual property and proven leadership. The organization has a portfolio of nine companies and operates primarily in North America.
Two River's expertise spans various sectors within life sciences, including oncology, immunotherapy, and synthetic and chemical biology. The firm has established itself as a key player in the life sciences investment landscape, emphasizing the importance of innovative partnerships to advance healthcare solutions. Its office is located at 689 Fifth Avenue, 12th Floor, New York, NY 10022.
Two River concentrates its investments in the life sciences sector, specifically targeting groundbreaking science that has the potential to transform patient outcomes. The firm invests at various stages, including seed, Series A, and Series B, providing capital to support scientific founders in advancing their research from bench to bedside.
Investment checks typically range from early-stage funding to larger rounds, depending on the specific needs of the portfolio companies. Two River's support extends beyond financial investment; it offers operational capabilities, corporate development, transaction support, and leadership recruitment to enhance the success of its portfolio companies. The firm seeks to partner with founders who possess strong scientific backgrounds and a clear vision for their innovations.
Two River's portfolio includes nine notable companies, each contributing to advancements in life sciences:
These companies represent a diverse range of innovative approaches to addressing critical health challenges, from cancer therapies to autoimmune disease treatments.
Arie Belldegrun, MD - Chairman & Partner. Dr. Belldegrun has extensive experience in the life sciences sector, having co-founded several successful biotech companies.
Joshua Kazam - Partner. Kazam brings a wealth of experience in venture capital and has been involved in numerous successful investments in the life sciences.
David Tanen - Partner. Tanen has a strong background in operational management and has played key roles in scaling biotech companies.
Chris Wilfong - Operating Partner. Wilfong specializes in operational support and has a track record of enhancing the performance of portfolio companies.
Nicole van de Leuv - Principal. Van de Leuv focuses on sourcing and evaluating new investment opportunities in the life sciences.
David Chang, MD, PhD - Venture Partner. Dr. Chang has a deep understanding of scientific research and its application in the biotech industry.
Sean Algeo - Chief Financial Officer. Algeo oversees financial operations and strategy for Two River.
Owen Witte, MD - Advisor. Dr. Witte provides insights into scientific advancements and their implications for investment.
James S. Economou, MD, PhD - Advisor. Dr. Economou offers expertise in oncology and therapeutic development.
To pitch Two River, founders should submit their proposals through the contact form on their website or reach out directly via phone. A detailed pitch deck should include information on the scientific innovation, market analysis, and team qualifications. Response times may vary, but founders can expect to hear back within a few weeks.
In recent months, Two River has continued to expand its portfolio, focusing on innovative life sciences companies. Notable investments include partnerships with companies developing therapies for blood cancers and autoimmune diseases.
The firm has also been active in supporting its existing portfolio companies through operational enhancements and leadership recruitment, ensuring they are well-positioned for growth in the competitive life sciences market.
What are Two River's investment criteria?
Two River invests in life sciences companies that demonstrate groundbreaking science with the potential to transform patient outcomes. They focus on companies with strong intellectual property and proven leadership.
How can I pitch Two River?
Founders can pitch Two River by reaching out through their website or contacting them directly at their office. A well-prepared pitch deck that outlines the scientific innovation, market potential, and team background is essential.
What makes Two River different from other VCs?
Two River differentiates itself by providing not only capital but also operational capabilities, corporate development support, and leadership recruitment to enhance the success of its portfolio companies.
What is the geographic focus of Two River?
The firm primarily invests in North America, targeting life sciences companies that are positioned to make significant impacts in healthcare.
What is the typical check size for investments?
Two River invests at various stages, including seed, Series A, and Series B, with check sizes varying based on the specific needs of the company and the stage of investment.
What kind of post-investment involvement does Two River have?
Two River actively supports its portfolio companies through operational capabilities, corporate development, and leadership recruitment, ensuring that they have the resources needed to succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.